• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过铜绿假单胞菌的最低抑菌浓度(MIC)恢复时间评估每日一次氨基糖苷类药物给药方案。

Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.

作者信息

Karlowsky J A, Zhanel G G, Davidson R J, Hoban D J

机构信息

Department of Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Antimicrob Agents Chemother. 1994 May;38(5):1165-8. doi: 10.1128/AAC.38.5.1165.

DOI:10.1128/AAC.38.5.1165
PMID:8067757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC188170/
Abstract

A novel, in vitro, pharmacodynamic comparison of single and divided daily dosing regimens of aminoglycosides is described. Experiments were conducted to evaluate the impact of gentamicin and tobramycin concentration on the time required for the MICs for five Pseudomonas aeruginosa strains to revert to their original values (MIC reversion time [MRT]) following single and multiple 2-h aminoglycoside exposures to 8 and 24 mg/liter. Single 2-h aminoglycoside exposures to 8 mg/liter produced culture MRTs (gentamicin, 21.5 +/- 4.0 h; tobramycin, 22.3 +/- 2.8 h) that were significantly (P < 0.05) shorter than those measured following identical exposures to 24 mg/liter (gentamicin, 28.9 +/- 3.8 h; tobramycin, 26.8 +/- 3.1 h). However, three sequential 2-h exposures to 8 mg/liter, one exposure every 8 h, produced MRTs following the third exposure (gentamicin, 68.1 +/- 5.2 h; tobramycin, 77.8 +/- 7.8 h) that were significantly longer (P < 0.005) than those determined following three 2-h exposures to 24 mg/liter, one exposure every 24 h (gentamicin, 36.1 +/- 3.0 h; tobramycin, 34.5 +/- 3.0 h). In addition, the once-daily exposure regimen to 24 mg/liter consistently produced cultures with significantly (P < 0.005) higher aminoglycoside concentration/MIC ratios compared with those for cultures reexposed to 8 mg/liter once every 8 h. These data support the concept of once-daily aminoglycoside dosing.

摘要

本文描述了一种新的体外氨基糖苷类药物单次给药与每日分次给药方案的药效学比较。进行实验以评估庆大霉素和妥布霉素浓度对5株铜绿假单胞菌菌株的最低抑菌浓度(MIC)在单次和多次2小时氨基糖苷类药物暴露于8和24mg/L后恢复到原始值所需时间(MIC恢复时间[MRT])的影响。单次2小时氨基糖苷类药物暴露于8mg/L产生的培养物MRT(庆大霉素,21.5±4.0小时;妥布霉素,22.3±2.8小时)显著(P<0.05)短于相同暴露于24mg/L后测得的MRT(庆大霉素,28.9±3.8小时;妥布霉素,26.8±3.1小时)。然而,连续三次2小时暴露于8mg/L,每8小时一次,在第三次暴露后产生的MRT(庆大霉素,68.1±5.2小时;妥布霉素,77.8±7.8小时)显著长于(P<0.005)三次2小时暴露于24mg/L,每24小时一次后测得的MRT(庆大霉素,36.1±3.0小时;妥布霉素,34.5±3.0小时)。此外,与每8小时重新暴露于8mg/L的培养物相比,每日一次暴露于24mg/L的方案始终产生氨基糖苷类药物浓度/MIC比值显著(P<0.005)更高的培养物。这些数据支持了氨基糖苷类药物每日一次给药的概念。

相似文献

1
Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa.通过铜绿假单胞菌的最低抑菌浓度(MIC)恢复时间评估每日一次氨基糖苷类药物给药方案。
Antimicrob Agents Chemother. 1994 May;38(5):1165-8. doi: 10.1128/AAC.38.5.1165.
2
Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro.铜绿假单胞菌在体外单次及多次接触氨基糖苷类药物后的抗生素后效应
J Antimicrob Chemother. 1994 May;33(5):937-47. doi: 10.1093/jac/33.5.937.
3
Changes in MIC alter responses of Pseudomonas aeruginosa to tobramycin exposure.最低抑菌浓度(MIC)的变化会改变铜绿假单胞菌对妥布霉素暴露的反应。
Antimicrob Agents Chemother. 1998 Jun;42(6):1365-9. doi: 10.1128/AAC.42.6.1365.
4
Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.通过基于机制的药代动力学/药效学模型优化针对耐碳青霉烯类和氨基糖苷类的临床铜绿假单胞菌分离株的协同联合治疗方案。
Antimicrob Agents Chemother. 2016 Dec 27;61(1). doi: 10.1128/AAC.01011-16. Print 2017 Jan.
5
Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development.氨基糖苷类药物对铜绿假单胞菌和鲍曼不动杆菌的药效学建模:确定抑制耐药性产生的给药方案。
Antimicrob Agents Chemother. 2008 Nov;52(11):3987-93. doi: 10.1128/AAC.01468-07. Epub 2008 Aug 25.
6
Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.通过机制研究和建模确定与碳青霉烯类药物协同作用所需的氨基糖苷类药物浓度对铜绿假单胞菌。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00722-17. Print 2017 Dec.
7
Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa.钙、镁和锌对替卡西林及妥布霉素单独使用及联合使用时抗铜绿假单胞菌的影响。
Antimicrob Agents Chemother. 1982 Nov;22(5):839-43. doi: 10.1128/AAC.22.5.839.
8
The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.庆大霉素、妥布霉素和奈替米星对500株临床分离菌的体外活性。使用三种不同测试培养基的比较研究。
Acta Pathol Microbiol Immunol Scand B. 1983 Apr;91(2):135-9. doi: 10.1111/j.1699-0463.1983.tb00022.x.
9
["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].庆大霉素、西索米星和妥布霉素对医院来源的铜绿假单胞菌菌株的“体外”活性(作者译)
Ann Sclavo. 1977 May-Jun;19(3):437-45.
10
[Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].四种氨基糖苷类抗生素(阿米卡星、庆大霉素、卡那霉素和妥布霉素)杀菌效果的比较(作者译)
Ann Microbiol (Paris). 1979 Apr;130A(3):331-43.

引用本文的文献

1
Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.比较囊性纤维化儿科及青少年患者每日一次使用妥布霉素的剂量调整方法。
Clin Pharmacokinet. 2015 Apr;54(4):409-21. doi: 10.1007/s40262-014-0211-9.
2
Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.ICU 患者接受每日一次方案时妥布霉素的处置:群体方法和剂量模拟。
Br J Clin Pharmacol. 2011 Jan;71(1):61-71. doi: 10.1111/j.1365-2125.2010.03793.x.
3
Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model.在体外药代动力学模型中模拟的妥布霉素一个给药间隔期间抗生素后效应的改变。
Antimicrob Agents Chemother. 1996 Mar;40(3):784-6. doi: 10.1128/AAC.40.3.784.
4
In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.铜绿假单胞菌中氨基糖苷类适应性耐药的体外特性研究
Antimicrob Agents Chemother. 1996 Jun;40(6):1387-93. doi: 10.1128/AAC.40.6.1387.

本文引用的文献

1
In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth.头孢噻肟、环丙沙星和庆大霉素多次暴露于合并的人脑脊液和穆勒-欣顿肉汤中对大肠杆菌产生的体外抗生素后效应。
Antimicrob Agents Chemother. 1993 May;37(5):1154-7. doi: 10.1128/AAC.37.5.1154.
2
In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.反复暴露于亚胺培南、替马沙星和妥布霉素后的体外抗生素后效应。
Antimicrob Agents Chemother. 1993 Aug;37(8):1723-5. doi: 10.1128/AAC.37.8.1723.
3
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
J Infect Dis. 1987 Jan;155(1):93-9. doi: 10.1093/infdis/155.1.93.
4
Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.
J Infect Dis. 1990 Aug;162(2):414-20. doi: 10.1093/infdis/162.2.414.
5
Human pharmacodynamics of beta-lactams, aminoglycosides and their combination.β-内酰胺类、氨基糖苷类及其联合用药的人体药效学
Scand J Infect Dis Suppl. 1990;74:235-48.
6
The postantibiotic effect: a review of in vitro and in vivo data.抗生素后效应:体外和体内数据综述
DICP. 1991 Feb;25(2):153-63. doi: 10.1177/106002809102500210.
7
Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin.
J Antimicrob Chemother. 1991 Jun;27(6):741-8. doi: 10.1093/jac/27.6.741.
8
Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.通过杀菌曲线法和抗生素后效应测定亚抑菌浓度氨基糖苷类药物对铜绿假单胞菌的抗菌活性。
Chemotherapy. 1991;37(2):114-21. doi: 10.1159/000238842.
9
Once daily aminoglycoside dosing: maintained efficacy with reduced nephrotoxicity?每日一次氨基糖苷类药物给药:疗效维持且肾毒性降低?
Ren Fail. 1992;14(1):1-9. doi: 10.3109/08860229209039110.
10
Pharmacodynamic factors of antibiotic efficacy.抗生素疗效的药效学因素。
Pharmacotherapy. 1992;12(6 Pt 2):64S-70S.